Patients with NF1 are born with a germline inactivating mutation in one copy of the NF1 gene (monoallelic or heterozygous NF1 loss) but may acquire a ‘second-hit’ mutation (biallelic NF1 loss) during development in susceptible cell types to induce glioma formation15,16. Here, NF1 is linked to central nervous system cancer.